PersonAuto-indexed · Unverified
Michael Berendt
McLean, US· Director
Named on 3 public capital-raising filings across 2 companies. Compiled automatically from public SEC filings — not verified by this individual.
Companies
Filings (3)
Retension Pharmaceuticals, Inc. raised $12.3M
Retension Pharmaceuticals, Inc.· Director· May 6, 2025
Response Pharmaceuticals, Inc. raised $3.9M
Response Pharmaceuticals, Inc.· Director· Jun 28, 2024
Retension Pharmaceuticals, Inc. raised $10.1M
Retension Pharmaceuticals, Inc.· Director· May 15, 2024
